Group One Trading’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
|
|||||
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $544K | Buy |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.26M | Buy |
|
|||||
|
2022
Q4 | – | Hold |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $271K | Sell |
|
|||||
|
2022
Q1 | $4.83M | Buy |
|
|||||
|
2021
Q4 | – | Hold |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2021
Q2 | – | Hold |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $21K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $879K | Buy |
|
|||||
|
2020
Q1 | $120K | Sell |
|
|||||
|
2019
Q4 | $767K | Sell |
|
|||||
|
2019
Q3 | $753K | Buy |
|
|||||
|
2019
Q2 | $417K | Buy |
|
|||||
|
2019
Q1 | $252K | Buy |
|
|||||
|
2018
Q4 | $19K | Sell |
|
|||||
|
2018
Q3 | $1.37M | Buy |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1.25M | Sell |
|
|||||
|
2017
Q3 | $1.13M | Buy |
|
|||||
|
2017
Q2 | $24K | Buy |
|
|||||
|
2017
Q1 | – | Hold |
|
|||||
|
2016
Q4 | – | Hold |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $694K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $969K | Buy |
|
|||||
|
2015
Q2 | $389K | Buy |
|
|||||
|
2015
Q1 | $108K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $588K | Buy |
|
|||||
|
2014
Q2 | – | Hold |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $111K | Sell |
|
|||||
|
2013
Q3 | $310K | Buy |
|
|||||
|
2013
Q2 | $76K | Buy |
|